Results 51 to 60 of about 2,584,847 (299)

Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality [PDF]

, 2012
BACKGROUND: Oxidative stress has been suggested to play a key role in the development of cardiovascular disease (CVD). The aim of our study was to investigate the associations of serum peroxiredoxin 4 (Prx4), a hydrogen peroxide-degrading peroxidase ...
Abbasi, A., Bakker, S.J., Beulens, J.W., Corpeleijn, E., de Jong, P.E., Gans, R.O., Gansevoort, R.T., Hillege, H.L., Navis, G., Peelen, L.M., Postmus, D., Schulte, J., Stolk, R.P., Struck, J., van der Harst, P.   +14 more
core   +2 more sources

Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk

Рациональная фармакотерапия в кардиологии, 2016
Aim. To study standardized all-cause mortality and cardiovascular mortality (or deaths due to diseases of the circulatory system) in Irkutsk and Moscow including assessment in gender and age subgroups.Material and methods. To compare mortality in the two
F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva   +2 more
doaj   +1 more source

CPX‐351 in High‐Risk Relapsed Pediatric Acute Leukemia: Real‐World Phase 1 Data Establishing the FDA‐Approved Dose

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background/Objectives Outcomes for pediatric relapsed/refractory (R/R) acute myeloid leukemia (AML) remain dismal. CPX‐351, a liposomal formulation of cytarabine and daunorubicin, may have less off‐target toxicities than traditional chemotherapies and has shown improved outcomes for adults with newly diagnosed therapy‐related AML.
Jonathan D. Bender, Lauren Pommert, Lori R. Backus, Andrea Bidwell, Courtney Blank, Erin H. Breese, Karen C. Burns, Adam Lane, Lynn H. Lee, Benjamin Mizukawa, Robin E. Norris, Maureen M. O'Brien, Daniel Peck, Christine Phillips, Thomas D. Ryan, Jennifer Young, Michael Absalon, John P. Perentesis   +17 more
wiley   +1 more source

Association of nonrefractive visual impairment with risk of all-cause and specific-cause mortality in the National Health and Nutrition Examination Survey, 1999 to 2008

BMC Public Health
Objective To investigate and describe the impact of nonrefractive visual impairment (NVI) and its severity on all-cause and cause-specific mortality, along with the latest estimations.
Siyu Gui, Xinchen Wang, Qianqian Wang, Lan Zhong, Jianchao Qiao, Yueyang Xu, Yiran Li, Zhihao Huang, Chengyang Hu, Fangbiao Tao, Xiaodong Sun, Heting Liu, Jie Gao   +12 more
doaj   +1 more source

The U Shaped Relationship Between High-Density Lipoprotein Cholesterol and All-Cause or Cause-Specific Mortality in Adult Population

Clinical Interventions in Aging, 2020
Yu-qing Huang,1 Xiao-cong Liu,1 Kenneth Lo,1,2 Lin Liu,1 Yu-ling Yu,1 Chao-lei Chen,1 Jia-yi Huang,1 Ying-qing Feng,1 Bin Zhang1 1Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital, Guangdong ...
Huang Y, Liu X, Lo K, Liu L, Yu Y, Chen C, Huang J, Feng Y, Zhang B   +8 more
doaj  

Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Secondary hyperparathyroidism (SHPT) is a common complication in patients receiving maintenance dialysis, driven by calcium and phosphate metabolism disturbances. Calcimimetics are central to the management of SHPT by enhancing calcium‐sensing receptor sensitivity and reducing parathyroid hormone secretion.
Fumihiko Koiwa, Daisuke Honda, Seigo Akari, Tadao Akizawa   +3 more
wiley   +1 more source

Adjunctive Therapeutic Plasma Exchange in Refractory Adult‐Onset Still's Disease Complicated by Secondary Macrophage Activation Syndrome: A Single‐Center Experience

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Adult‐onset Still's disease (AOSD) complicated by macrophage activation syndrome (MAS) carries substantial mortality. The role of therapeutic plasma exchange (TPE) remains uncertain. Methods We retrospectively analyzed patients with AOSD‐MAS treated with TPE at a single‐center.
Masataka Ueda, Tomohiro Saito, Masahide Mizobuchi, Tomoki Shimomura, Saki Kawamori, Mitsuru Kawanishi, Natsuko Hattori, Jo Sugiyama, Satoshi Tsubata, Hanami Horiguchi, Kazuki Abe, Nao Iida, Yuki Kajio, Nao Oguro, Ryo Yanai, Hirokazu Honda   +15 more
wiley   +1 more source

All‐cause mortality and Japan's early countermeasures

Health Science Reports
Søren Roest Korsgaard
openaire   +3 more sources

All-cause mortality following a cancer diagnosis amongst multiple sclerosis patients: A Swedish population-based cohort study [PDF]

, 2015
Background and purpose: A reduced cancer risk amongst patients with multiple sclerosis (MS) has been reported. Theoretically, this could represent a genuine reduction in risk or, alternatively, 'diagnostic neglect', where cancer is undiagnosed when ...
Bahmanyar, S., Hillert, J., Montgomery, S., Olsson, T., Roshanisefat, H.   +4 more
core   +1 more source

The Role of Cancer in the Risk of Cardiovascular and All-Cause Mortality: A Nationwide Prospective Cohort Study

International Journal of Public Health, 2023
Objectives: Evidence on cardiovascular-related and all-cause mortality risks in a wide range of cancer survivors is scarce but needed to inform prevention and management.Methods: We performed a nationwide prospective cohort study using information from ...
Ruihuan Shen, Ruihuan Shen, Jia Wang, Rui Wang, Rui Wang, Yuqing Tian, Yuqing Tian, Peiyao Guo, Shuhui Shen, Shuhui Shen, Donghao Liu, Tong Zou, Tong Zou   +12 more
doaj   +1 more source